NEURONAL CELL DEATH IN HIV-1 INFECTION
Despite the absence of productive infection of neurons, HIV-1 infection has been associated with neuronal loss in distinct regions of the brain, including the frontal cortex,65-67 the substantia nigra,68 the cerebellum,69 and the putamen.70 Neuronal loss in the frontal cortex and in other regions of the neocortex has been estimated between 18 and 38%.65-67 Select neuronal subpopulations, including larger pyramidal cells within the cortex, are at greater risk of cell death and, similarly, neuronal populations that express certain neurotransmitters (e.g., GABA) and proteins (e.g., parvalbumin and calbindin) are more likely to be diminished in the HIV-1-infected brain.71
Cellular injury and loss in the brain during HIV-1 infection are also evident from magnetic resonance imaging and spectroscopy studies that revealed brain atrophy in HIV-1-infected patients occurring within cortical, central, brain stem, and cerebellar regions.72-76 In some studies, the severity of atrophy was correlated with advanced stages of HIV-1 infection72,73 or with clinical signs of cognitive impairment.72,73,75 Although necrosis of neurons was demonstrated in HAD patients,77 it was hypothesized as early as 1990 that the neuronal loss observed in HIV-1-infected patients may also be due to apoptosis.65,66 Apoptosis is an active process of cell death, characterized by cell shrinkage, chromatin aggregation with genomic fragmentation, and nuclear pyknosis.78,79 In vivo, phagocytic cells normally sequester antigenically modified apoptotic cells, preventing inflammation and damage to the surrounding tissue.80 In contrast, necrosis is characterized by passive cell swelling and disruption of internal homeostasis, resulting in membrane lysis and release of intracellular constituents that induces a local inflammatory reaction with subsequent injury to the surrounding tissue.81 If apoptotic neurons are not phagocytosed in a timely fashion, however, secondary necrosis may occur, producing ultrastructural phenotypes characteristic of both apoptosis and necrosis.82-84 It has been suggested that the intensity of the initial insult dictates whether neurons undergo apoptosis or necrosis; a severe initial challenge will result in necrosis, whereas a milder challenge triggers apoptotic signals via p38 MAPK.82
With the development of TUNEL (terminal deoxynucleotidyl dUTP nick end labeling), a technique that identifies the free 3-OH ends of newly cleaved DNA in situ,85 several groups in the mid-1990s demonstrated that neuronal damage in both adult and pediatric AIDS was, in part, due to apoptosis.86-89 However, neuronal apoptosis seems to be a feature of AIDS, as only rare apoptotic neurons were demonstrated in a few pre-AIDS cases.87,90 Whether a direct correlation exists between the degree of neuronal apoptosis and the severity of neurological cognitive disorders observed in HIV-1 infection remains unclear.
In one study, Adle-Biassette et al. characterized apoptotic neurons in several regions of the brain (including the frontal and temporal cortex, basal ganglia, and brain stem) taken postmortem from 20 HIV/AIDS patients.91 In this study, no global correlation was observed between neuronal apoptosis and cognitive dysfunction, the presence of HIVE, or microglial activation. However, within the cerebral cortex, neuronal apoptosis correlated with cerebral atrophy. Moreover, within the basal ganglia, apoptotic neurons seemed to be more abundant in the vicinity of activated microglia, which contained HIV-1 p24 immunoreactivity, suggesting that some topographical associations may exist. Furthermore, Gelbard et al. demonstrated that apoptotic neurons in the cerebral cortex and basal ganglia of children with HIVE were present in the vicinity of perivascular inflammatory cell infiltrates containing HIV-1 infected macrophages and multinucleated giant cells.88TUNEL analysis also identified DNA strand breaks in the DRG of HIV-1-infected individuals.92 TUNEL-positive neurons were observed only in the DRG of patients with AIDS and were more abundant in patients with peripheral neuropathy. However, TUNEL-positive neurons did not correlate with neuronal loss or demonstrate morphological features of apoptosis, suggesting that these neurons might be “primed” to apoptosis rather than fully committed to apoptosis.
In addition to neuronal cell death, apoptosis of other CNS cell types in the brains of HIV/AIDS patients was reported, including astrocytes86,89,93 and, more rarely, multinucleated giant cells.86 In addition, astrocyte apoptosis was demonstrated in primary human brain cultures following exposure to HIV-1.89 Significantly greater numbers of apoptotic astrocytes were detected in the brains of HIV/AIDS patients with rapidly progressing dementia compared with slow progressors,93 and detection of apoptotic astrocytes seemed to be more common in HAD patients compared with nondemented HIV/AIDS patients,89 suggesting a role for astrocyte cell loss in the neuropathogenesis of HAD.
Given the trophic role of astrocytes in the CNS, HIV-1-mediated astrocyte cell death may result in several deleterious events, including alterations in the composition of the extracellular environment (e.g., concentrations of excitotoxic neurotransmitters such as glutamate), reduced production of neurotropic factors, and impaired maintenance of the blood-brain barrier. Several studies in AIDS patients have demonstrated CNS microvascular abnormalities and increased blood-brain barrier permeability.94-96 HIV-1 Tat was shown to induce apoptosis of human brain microvascular endothelial cells in vitro via a nitric oxide-mediated mechanism,97 and apoptotic endothelial cells were identified in the brain of HIV/AIDS patients.89 Thus, HIV-1-induced endothelial cell apoptosis may contribute to the microvascular pathologies observed in HIV/AIDS patients. Animal models of HAD also revealed cell death via apoptosis in the CNS after lentivirus infection, when infection of macaques with a neurovirulent strain of another lentivirus, simian immunodeficiency virus (SIV), resulted in apoptosis of neurons, endothelial cells, and glial cells.98Although there is no clear consensus as to the underlying mechanism of HIV-induced neuropathogenesis, two main theories dominate (Figure 22.1). First, although HIV-1 does not infect neurons productively, if at all, HIV-1-encoded proteins may injure neurons directly without requiring the intermediary functions of nonneuronal cells. Alternatively, neuronal apoptosis may result indirectly from the secretion of neurotoxic factors by resident brain macrophages or microglia in response to HIV-1 infection, stimulation by viral proteins, or immune activation. These two theories are in no way mutually exclusive, and current data exist to support each hypothesis.